First Standard Treatment Improves Survival for People with Advanced Bi
- This topic has 9 replies, 3 voices, and was last updated 15 years, 2 months ago by
.
-
Posts
-
This is the link to the above mentioned development:
http://www.hemonctoday.com/article.aspx?rid=39941
This is the podcast. You may want to fast-forward it to reach the discussion about above development:
http://www.cancer.net/patient/Library/Podcasts/2009_AM_Advance_Presscast.mp3
Thank you Hope,
who was so kind as to forward the following:First Standard Treatment Improves Survival for People With Advanced Biliary Tract Cancer
Treatment with the drugs cisplatin (Platinol) and gemcitabine (Gemzar) increased survival and slowed cancer growth for people with biliary tract cancers (gallbladder and bile duct cancers) that could not be removed with surgery. Patients who received these two drugs were 32% less likely to die from the disease and 30% less likely to have the cancer grow than the patients who received only gemcitabine.
What this means for patientsKristin, this is the response in it’s entirety. Although, I still can’t open the link we had been waiting for however, here are a few others you might want to peruse. I will try to reach Hope, again.
Hi Marion,
Thank you for clarifying. The article you are referring to will be presented at ASCO
Kristen…I have contacted Cancer.Net and am awaiting their response as to where to this link has been moved. The upcoming theme at ASCO for 2009 is “Personalizing Cancer Care” in which this particular study will be presented. If I don’t receive a response of my question from Cancer.Net before my attendance of this conference, I will be sure to attend this particular session in Florida and I will then post acccordingly.
Waiting along with you,
Marion
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.